documents: FDA-2026-N-0027-0003

Federal regulatory documents currently open for public comment. ⚠ Derive comment deadlines from comment_end_datetime converted to America/New_York, never from comment_end_date, which is mid-correction and may be one day late (DataDawn queue #498).

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	agency_id	docket_id	title	document_type	subtype	posted_date	posted_year	posted_month	comment_start_date	comment_end_date	comment_end_datetime	perpetual_docket	last_modified	fr_doc_num	open_for_comment	withdrawn	object_id
FDA-2026-N-0027-0003	FDA	FDA-2026-N-0027	Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing	Notice	30 Day Proposed Information Collection	2026-09-16	2026	9	2026-09-16	2026-10-16	2026-10-17 03:59:59	0	2026-09-16 17:00:39	2026-18946	1	0	09000064b956b6ef